Menu
  • Join us
  • Login
 

Search for abstracts

You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.


EFFICACY AND SAFETY OF SAXAGLIPTIN、SITAGLIPTIN PLUS METFORMIN FIXED-DOSE COMBINATION AS ADD-ON THERAPY WITH DUAL COMBINATION OF TRADITIONAL ORAL HYPOGLYCEMIC AGENTS IN TYPE 2 DIABETES MELLITUS

  • In: Poster Session
  • At: Düsseldorf (Germany) (2015)
  • Type: Poster
  • By: HU, Chun-Liang (Tainan Municipal Hospital, pharmacy, Tainan, China Taiwan)
  • Co-author(s): Chun-Liang Hu
  • Abstract:

    Less data confirm what kind of dipeptidyl peptidase-4 inhibitors/Metformin fixed-dose combination (DPP4I/Met FDC) medicine is more effective and safe when type 2 diabetes mellitus (T2DM) patients need additional medicines to meet glycemic targets.

    We retrospectively screened the data of T2DM patients who received Saxagliptin/Metformin 5/1000mg

    ..

  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 23 September 2026

FIP Congresses